• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Pharmexcil

Pharmexcil News

Business

Trump's Tariff Threat on Indian Pharma: A Counterproductive Move That Could Cost America Dearly

Olivia Carter 08 Aug, 2025

US President Donald Trump's decision to impose additional tariffs on Indian imports, excluding the pharmaceutical sector, highlights India's crucial role in affordable healthcare. ...

Popular News

  • Business

    RBI Governor Assures Strong Economy Amid Global Challenges, Clarifies Status of Rs 2,000 Notes

    11 Jul, 2025
  • Business

    Halliburton Faces a Slight Revenue Dip in Q4 2024, Yet Optimistic for Future Growth

    22 Jan, 2025
  • Market

    Global Gold Prices Surge Amid Falling Rates, Vietnam Outpaces with Higher Valuations

    17 May, 2025
  • Business

    November Sees Sluggish Sales for Passenger and Commercial Vehicles

    10 Dec, 2024
  • Market

    European Markets Dip as Merz Takes Helm: A Detailed Look at Tuesday's Financial Downturn

    07 May, 2025
  • Business

    India Joins Elite Top 25 Global Arms Exporters, Nirmala Sitharaman Reveals

    13 Jan, 2025
  • Business

    Samsung Electronics Expands Global Reach with €1.5 Billion Acquisition of German HVAC Leader FlaktGroup

    14 May, 2025
  • Business

    Resilience Amidst Tariffs: How India's Stock Market Stands Strong Against Trump's 25% Tariff Announcement

    31 Jul, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.